Neurohypophyseal diabetes insipidus
MONDO:0007450Hereditary central diabetes insipidus is a rare genetic subtype of central diabetes insipidus (CDI) characterized by polyuria and polydipsia due to a deficiency in vasopressin (AVP) synthesis.
Also known as: ADH deficiency, AVP deficiency, Arginine vasopressin deficiency, antidiuretic hormone deficiency, diabetes insipidus of pituitary gland, hereditary CDI, hereditary neurogenic diabetes insipidus, pituitary gland diabetes insipidus
11 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsBroader categories
-
Could a diabetes drug protect kidneys in children with genetic disease?
Disease control Recruiting nowThis study tests whether adding dapagliflozin (a diabetes drug) to standard care reduces protein leakage in the urine of children with hereditary kidney diseases. About 44 children will receive either dapagliflozin plus standard care or standard care alone for 12 weeks, then swit…
Phase: PHASE3 • Sponsor: Children's Hospital of Fudan University • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Hormone pill could unlock diagnosis of rare oxytocin deficiency in teens
Diagnosis Recruiting nowThis early-phase trial is testing whether a single dose of a hormone pill can help diagnose oxytocin deficiency in young people with hypopituitarism. Researchers will give the pill to 20 participants and measure oxytocin-related substances in blood and saliva. The goal is to deve…
Phase: EARLY_PHASE1 • Sponsor: Massachusetts General Hospital • Aim: Diagnosis
Last updated Jul 25, 2026 00:00 UTC
-
New test could make diagnosis of thirst disorders easier for patients
Diagnosis Recruiting nowThis study compares a new diagnostic test using mannitol infusion to the standard hypertonic saline test for diagnosing the cause of polyuria-polydipsia syndrome (excessive urination and thirst). Researchers will enroll 144 adults to see if the mannitol test is as accurate and mo…
Phase: NA • Sponsor: University Hospital, Basel, Switzerland • Aim: Diagnosis
Last updated Jun 27, 2026 14:00 UTC
-
Could a nasal spray ease anxiety in a rare hormone disorder?
Symptom relief Recruiting nowThis pilot study is testing whether an oxytocin nasal spray can help with anxiety, depression, and social functioning in adults with arginine-vasopressin deficiency, a rare hormone disorder. In the first part, 30 participants will receive single doses of oxytocin or placebo and c…
Phase: PHASE1 • Sponsor: Elizabeth Austen Lawson • Aim: Symptom relief
Last updated Jul 25, 2026 00:00 UTC
-
Can a 'Love Hormone' spray boost sexual health in diabetes insipidus?
Symptom relief Recruiting nowThis phase 2 trial tests whether oxytocin nasal spray can improve sexual well-being in people with central diabetes insipidus, a condition that also causes oxytocin deficiency. The study includes 42 participants (patients and healthy controls) and uses a double-blind, placebo-con…
Phase: PHASE2 • Sponsor: University Hospital, Basel, Switzerland • Aim: Symptom relief
Last updated Jun 27, 2026 07:53 UTC
-
Could a simple estrogen pill reveal hidden oxytocin deficiency?
Knowledge-focused Recruiting nowThis study is testing whether taking estrogen pills (estradiol valerate or ethinylestradiol) can safely trigger the release of oxytocin, a hormone important for social bonding and childbirth. Researchers will measure oxytocin levels in 28 healthy volunteers and patients with AVP …
Phase: NA • Sponsor: University Hospital, Basel, Switzerland • Aim: Knowledge-focused
Last updated Aug 13, 2026 00:00 UTC
-
Blood marker may predict brain surgery complication in kids
Knowledge-focused Recruiting nowThis study looks at whether measuring a substance called copeptin in the blood can help doctors diagnose central diabetes insipidus (CDI) in children after brain surgery. CDI causes extreme thirst and frequent urination due to a hormone imbalance. The study will track copeptin le…
Sponsor: Children's Hospital of Fudan University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
Music tweaked by tech may raise 'Love Hormone' levels
Knowledge-focused Recruiting nowThis study tests whether music enhanced with sonic augmentation technology can increase oxytocin (a hormone linked to social bonding) with few side effects. Researchers will compare the modified music to regular music in 22 healthy adults and patients with AVP-deficiency. The goa…
Phase: NA • Sponsor: University Hospital, Basel, Switzerland • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC